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Abstract Computational topologists recently developed a method, called persistent
homology to analyze data presented in terms of similarity or dissimilarity. Indeed,
persistent homology studies the evolution of topological features in terms of a sin-
gle index, and is able to capture higher order features beyond the usual clustering
techniques. There are three descriptive statistics of persistent homology, namely
barcode, persistence diagram and more recently, persistence landscape. Persistence
landscape is useful for statistical inference as it belongs to a space of p−integrable
functions, a separable Banach space. We apply tools in both computational topology
and statistics to DNA sequences taken from Clostridioides difficile infected patients
treated with an experimental fecal microbiota transplantation. Our statistical and
topological data analysis are able to detect interesting patterns among patients and
donors. It also provides visualization of DNA sequences in the form of clusters and
loops.
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1 Introduction
Topological data analysis has become a formidable technique for analyzing high-
dimensional data, especially when the purpose is for classification and discrimi-
nation. Methodological advancement has been rampant along with applications to
medical or scientific data, see for example [25], [11] and more recently [15]. In this
paper we propose making use of computational topological techniques to analyze
gut microbiome data at the basic DNA sequence level based on data collected from
sequencing the 16S rRNA gene. We are particularly interested in seeing changes
in patient gut microbiome for a certain hypervirulent infectious disease following
a radical experimental procedure that is gaining widespread attention and usage in
medicine.
Clostridioides (formerly Clostridium) difficile (C. difficile) infection (CDI) is the
most frequent cause of healthcare-associated infections and its rates are growing in
the community [13, 20]. One of the major risk factors for developing CDI is through
antibiotics. The healthy and diverse bacteria which reside within the colon are the
major defense against the growth of C. difficile. Antibiotics kill these bacteria and
allow C. difficile to multiply, produce toxins and cause disease. The current standard
of care for this infection are the antibiotics: metronidazole, vancomycin and more
recently, fidaxomicin. The efficacy of these antibiotics is limited as vancomycin and
metronidazole also suppress the growth of anaerobic bacteria such as Bacteriodes
fragilis group which protect against proliferation of C. difficile. The efficacy of the
recent narrower spectrum fidaxomicin is still under investigation although the initial
data shows promise, [21]. The persistent disruption of healthy colonic flora may in
part explain the reason for recurrences following a course of treatment with these
antibiotics.
As an alternative to antibiotic therapy for CDI, in particular for recurrent and re-
fractory diseases, is to infuse healthy gut bacteria directly into the colon of infected
patients to combat C. difficile by a procedure known as fecal microbiota transplan-
tation (FMT). FMT is a process in which a healthy donor’s stool is infused into
an affected patient. This can be performed using a colonoscope, nasogastric tube,
enema, or more recently, in capsulized pill form, [14]. FMT serves to reconstitute
the altered colonic flora, in contrast to treatment with antibiotic(s), which can fur-
ther disrupt the establishment of key microbes essential in preventing recurrent CDI.
The literature reveals a cumulative clinical success rate of over 90% in confirmed
recurrent CDI cases [9].
There has been a growing interest into the microbiome of CDI patients [4, 22, 36,
26, 30] especially those involved with FMTs [32, 35, 10, 33, 37, 31]. In case of the
latter, there are differences in: the route of administration with all forms covered;
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different donor selection criteria, some used family members, some used a pool of
donors; different sample sizes, although all studies had small sample sizes; and dif-
ferent sequencing procedures and equipment. Despite these differences, there seems
to be two fundamental points of agreement across all studies. The first is that CDI
patients have low diversity in their microbiome, and that after receiving an FMT(s),
their diversity was increased. The second fundamental agreement is CDI patients
who were treated with FMT undergo changes in their microbiome that at least ini-
tially have similarities to that of their donors. This paper provides further reinforcing
evidence to support these two fundamental points in the framework of FMT deliv-
ered by enema, with a small exclusive donor pool. The novelty comes from using
computational topological techniques to demonstrate this.
We now summarize the paper. In Section 2 we explain the details of the clini-
cal data. In Section 3 we provide topological preliminaries where we go over the
Vietoris-Rips complex, and three topological descriptors: barcodes, persistence dia-
grams, and persistence landscapes. In the following Section 4, we apply these tech-
niques and demonstrate the added value of the topological approach at the basic
DNA sequence level. We complete our article in Section 5 with a summary of the
key findings.
2 CDI FMT and 16S rRNA data
An earlier report provided details with regard to donor screening and the protocol
used [12]. Including the earlier study, FMT was administered to 94 patients and
several patients required multiple FMTs to achieve resolution [17]. From this patient
pool we selected 19 patients, not necessarily randomly, for sequencing their 16S
rRNA gene prior to treatment, pre-FMT, followed by a post treatment, post-FMT.
Consequently, the data that is about to be presented should not be interpreted with
respect to the efficacy of FMT, as the purpose is to better understand the microbial
changes that came about as a result of an FMT(s).
The gender of the patients was 63% female. The average age (to the time of their
first FMT) was 77.11 with a standard deviation of 9.54 years, range 49 to 92 years.
In-hospital patients accounted for 53% while the total peripheral white blood count
(×109/L) had a mean and standard deviation of 14.6 and 10.87, respectively. Three
patients had temperature greater than 38o C, and 11 patients experienced abdomi-
nal pain. Approximately half (53%) of the patients were on proton-pump inhibitors.
Eight patients were refractory to treatment with metronidazole and four patients
were refractory to vancomycin. These four patients were also refractory to metron-
idazole. No patients were on fidaxomicin as it had not been available to the public
at that time. The patient characteristics are provided in Table 1, below.
Predisposing conditions that may have resulted in CDI were: cellulitis, ex-
treme fatigue, respiratory tract infections, septicemia, surgery and open wounds,
and urinary tract infections. Some conditions were unknown. The majority of
patients received the following antibiotics prior to contracting CDI: amoxicillin,
4 P Petrov ST Rush Z Zhai CH Lee PT Kim G Heo
Covariate
Age–years
Mean ± Standard Deviation 77.11±9.54
Range 49–92
White Blood Count–×109 per litre
Mean ± Standard Deviation 14.6±10.87
Range 5–40
Female–count(%) 12 (63%)
In-hospital–count(%) 10 (53%)
Fever–count(%) 3 (16%)
Abdominal Pain–count(%) 11 (58%)
Proton pump inhibitor–count(%) 10 (53%)
Refractory to Metronidazole(%) 8 (42%)
Refractory to Vancomycin(%) 4 (21%)
Table 1 Patient demographics and pre-FMT conditions.
azithromycin, cefazolin, cefprozil, cephalexin, ciprofloxacin, clindamycin, clar-
ithromycin, cloxacillin, levofloxacin, moxifloxacin and nitrofurantoin. Some pa-
tients claimed no prior antibiotics used. In an interesting paper, the affects of
ciprofloxacin was studied [4] using 16S rRNA deep sequencing.
The patients all had varying pre-FMT regimens to treat their CDI. All had un-
dergone multiple rounds of traditional antibiotic therapy with metronidazole and/or
vancomycin before being administered an FMT. Seventeen received at least one
course of metronidazole monotherapy, 18 received vancomycin monotherapy, 6
received vancomycin taper, and 3 received concomitant metronidazole and van-
comycin therapy. Patients generally received two courses of metronidazole followed
by multiple courses of vancomycin before receiving FMT(s). The number of days
every patient received each therapy are summarized by their means and standard
deviations and reported below in Table 2.
Each patient had two stool samples sequenced, one representing a pre-FMT se-
quence, and one representing a post-FMT sequence. We attempted to sequence each
patient prior to them receiving any FMT which for the most part occurred except for
one patient who failed their first FMT and their stool sample sequenced was taken
right after that event but prior to their next FMT. This patient had multiple FMT
failures, hence we took that stool sample as the pre-FMT sequence. We also took
a stool sample following each patient’s pre-FMT sample with at least one FMT in
between. For the most part, the latter occurred following their last FMT which was
the case if the patient resolved their CDI, but if they did not, then the post-FMT
sequence was not necessarily their last. We would also like to make clear that 4+-
FMT means that a patient had at least four treatments but could have had more. We
indicate such as ‘4+’ to be consistent with our clinical paper, [17].
The breakdown of the data is presented in Table 3 with the above qualifications.
All patients received a single treatment, 1-FMT and 9 of them clinically resolved
their CDI. All who failed the first treatment went on to receive a second treatment.
Of the remaining patients who received 2-FMT, 2 resolved, while the remaining
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Standard of Care Treatment
Metronidazole(%) 17 (90%)
Metronidazole–days
Mean ± Standard Deviation 23.74± 16.51
Range 01–70
Vancomycin(%) 18 (95%)
Vancomycin–days
Mean ± Standard Deviation 32.58± 20.94
Range 7–86
Vancomycin Taper(%) 6 (32%)
Vancomycin Taper–days
Mean ± Standard Deviation 37.58± 93.86
Range 38–390
Metronidazole-Vancomycin(%) 3 (16%)
Metronidazole Vancomycin–days
Mean ± Standard Deviation 5.21± 18.55
Range 2–80
Table 2 Pre-FMT treatment for CDI.
went onto to receive a third treatment. There were 2 successes, and 1 failure, mean-
ing they did not go on to receive additional treatments. Of the remaining patients
who went on to 4+-FMT, 1 resolved, 1 resolved with antibiotics used in between
treatments, and there were 3 failures.
FMT Resolution Resolution* Failures Total
1 9 - 0 9
2 2 - 0 2
3 2 - 1 3
4+ 1 1 3 5
- 14 1 4 19
Table 3 Clinical resolution of CDI following FMT(s). Patients who received antibiotics in-
between FMTs are marked with an asterisk.
There were several patients who received antibiotics in between FMTs as de-
scribed in our previous report [17]. In addition four healthy volunteers served as
donors and were screened for transmissible pathogens as was outlined in an earlier
report [12]. The donors took no antibiotics for 6 months prior to stool donation.
Seven donor samples taken at various times were sequenced.
All C. difficile infections were confirmed by in-hospital real-time polymerase
chain reaction (PCR) testing for the toxin B gene. This study sequenced the forward
V3-V5 region of the 16S rRNA gene from 19 CDI patients who were treated with
FMT(s). A pre-FMT, a corresponding post-FMT, and 7 samples from four donors,
corresponding altogether to 45 fecal samples were sequenced. All sequencing was
performed on the 454 Life Sciences, GS Junior Titanium Series. The Qiagen Stool
Extraction Kit (Omega BIO-TEK, Norcross, Georgia) was used to extract the DNA
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from the fecal samples following the ‘stool DNA protocol for pathogen detection’.
Subsequent DNA amplification was done using PCR forward and reverse primers.
One round of DNA amplicon purification was performed using the QIAquick PCR
Purification Kit (Qiagen, Valencia, CA) followed by two rounds of purification using
Agencourt AMPure XP beads (Beckman Coulter Inc., Mississauga, ON).
We examined 19 pairs of pre-FMT and post-FMT patients, as well as donors, se-
lected from the 94 CDI patients treated by the first author over the period 2008-12,
[17]. The selection was not random and was chosen to reflect as wide a variability
as possible. Furthermore, we deliberately chose 4 FMT failures to try and better
understand what FMT can and cannot do. It was perhaps through the failures that
we learned the most. The failed FMT cases were ultimately resolved with antibi-
otics even though some patients were refractory to metronidazle and/or vancomycin
beforehand. Indeed FMT acted as a ‘gut primer’ for antibiotics to fulfill it’s role in
clearing recurrent and refractory CDI. Although this phenomenon of failed FMT
patients resolved with antibiotics afterwards has been observed in our work, [17], as
well as others, see for example [27], as far as we are aware this is the first paper that
has pursued this from a microbiome point of view. The data comes from the clinical
work of the fourth author who is a practising physician. Some of this data was also
examined in [23] and [29].
Table 4 below, provides some descriptive statistics about the total and unique
number of DNA sequences found in the 45 samples. Note that it is impossible to
ensure that we have an approximately equal number of sequences in each sample
[19].
min max mean median S.D.
Pre-FMT 147 (3230) 879 (15140) 428.89 (9534.9) 364 (9777 ) 217.26 (3545.9)
Post-FMT 185 (2294) 1114 (28566) 486.42 (11308.11) 460 (10570) 230.57 (6642.6)
Table 4 Descriptive statistics for unique (total) number of DNA sequences of pre-FMT and post-
FMT samples.
Consider the DNA sequences λ and µ . Let x be the number of point dissimi-
larities between DNA bases in λ and µ , and let xλ and xµ be the number of DNA
bases in λ and µ , respectively. Let xO be the number of places where one sequence
contains a DNA base and the other an O, a gap. Let yλ and yµ be the number of gaps
in λ and µ , respectively. Let z be the length of the alignment sequences; we can
assume they are equal otherwise we choose the smaller. The various dissimilarity
metrics are the following.
The one-gap distance dO is defined by
dO(λ ,µ) =
x+min{yλ ,yµ}
min{xλ + yλ ,xµ + yµ}
.
It treats a string of O’s flanked by any DNA bases in one sequence and the corre-
sponding region in the other as one mismatch.
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The no-gap distance dN is defined by
dN(λ ,µ) =
x
min{xλ ,xµ}
.
It ignores gaps in a sequence and the corresponding region in the other sequence.
The each-gap distance dE is defined by
dE(λ ,µ) =
x+ xO
z
.
It treats every DNA base-placeholder pair as a mismatch.
These metrics produce true mathematical distance matrices, which are symmetric
and contain zeros on the diagonal. For this and most studies, the metric of interest is
the one-gap metric, [28]. As an example, suppose there are two DNA sequences with
the following base pair orientation: ATGCATGCATGC and ACGC---CATCC. Here
there are two mismatches and one gap. The distance is calculated as the number of
mismatches divided by length of the shorter sequence. The length of the shorter se-
quence is 10 base pairs, since the gap is considered a single position. Hence distance
is 0.3, [28]. We can use the other definitions of distance, but the definition provided
is the one most commonly used. In addition, the results do not vary significantly.
Most of the DNA sequences found in the samples appear several times, and hence
the distance between them will be zero as they are identical. For this reason, the
unique DNA sequences are taken.
Table 4 shows the minimum number of unique sequences is 147. DNA sequenc-
ing does not provide exact results, hence as the number of sequences in a sample
increases, some mutations inevitably occur and these are recorded as unique se-
quences [28]. In other words, as the total number of sequences increases, the num-
ber of unique sequences is also inflated. For this reason, it is necessary to subsample
from the number of unique sequences. The smallest number of unique sequences is
147, hence a weighted subsample of size 147 is taken from the number of unique
sequences for our research. The pairwise distance between the 147 sequences is cal-
culated in each of the 45 samples using the one-gap metric. Thus the data used for
the primary analysis is 147 × 147 distance matrices for each of the 45 patients and
donors.
3 Some Topological Preliminaries
Persistent homology is a branch of computational topology that has been popu-
larized by [7] and [38]. Several researchers have shown that persistent homology
works well on detecting topological and geometrical features in high dimensional
data, see [5] and [25], for example. Let us suppose that we have points on a mani-
fold whose dimension is not necessarily known. Topology studies the connectivity
of these points. Each point is replaced by a disk (ball) with radius ε centered at each
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point. If the disks overlap, connect those center points with edges. As the radius in-
creases, more points will be connected and so the number of connected components
will decrease. This is analogous to clustering analysis in statistics. The connected
components (clusters) are considered as 0-degree topological features. The number
of connected components is denoted as the 0-th Betti number, β0. Connecting the
points with edges will also create simplices (convex hull of a geometrically inde-
pendent set of points) and produce topological features in higher dimensions. The
low dimensional simplices are well known; a vertex (0-degree simplex), an edge
(1-degree simplex), a triangle (2-degree simplex), and a tetrahedron (3-degree sim-
plex). A loop is also called a 1-degree topological feature and a void is a 2-degree
topological feature. The k−th Betti number βk counts the number of k−degree topo-
logical features (k−dimensional ‘holes’).
Persistent homology studies the history of topological features as the parameter
ε varies. It records the time at which a topological feature appears and disappears.
The birth, death, and survival time of features are recorded as a barcode [3]. A true
feature in the data lives over a long time while noise is short lived. We illustrate
a fundamental idea of persistent homology in Figure 1 with 40 randomly selected
points from a double annulus. The loops in the middle of each annulus are prominent
1-degree features and their intervals in the barcode shows their persistence.
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Fig. 1 Forty points are sampled randomly from a double annulus with inner circle radius 1 and
outer circle radius 2. Forty components (top left) yield β0 = 40 at ε = 0; nineteen (top middle)
connected components, that is, β0 = 19 at ε = 0.5; top right β0 = 5 at ε = 1.0; the two most
persistent loops (bottom left and middle) in the middle of the double annulus that are born at about
ε = 1.5 die around ε = 2.4 showing two ‘true’ persistent loops. The long (0,∞) bar in β0 (bottom
right) barcode indicates the one persistent component while two longer bars in β1 barcode indicate
two loops.
Clusters come in different shapes, see a few synthetic examples in Figure 2. Clus-
ters are homogeneous subgroups where the meaning of homogeneity is dependent
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on the types of similarity measure. In the double annulus, Figure 1, if we consider
geodesic distance between points, those points are connected to form simplices
(edges and triangles). All the edges and triangles together form a band which is
homotopy equivalent to a circle (1-degree topological feature). The authors in [1]
applied support vector clustering to concentric rings and were able to detect three
rings as clusters. In Figure 3, we generate similar concentric rings as in [1]. Per-
sistent homology analysis shows three persistent loops which correspond to three
clusters in [1]. Consider another example, where points are randomly sampled from
the number 8 with noise, see Figure 3. What are the clusters in this data? If one
thinks of ‘blobs’ as clusters, there are several patches made up with a few points.
However, each loop, 1-degree topological feature, is represented as the set of points
which are close in the sense of the shortest path distance.
Fig. 2 Synthetic examples of clusters in different forms. From ‘blobs’-intuitively familiar clusters,
to curves, ‘leaves’, and Swiss roll.
Fig. 3 Top: random points are generated to mimic concentric rings analysed in [1]. The three long
intervals in the barcode shows three persistent loops. The three persistent loops are drawn which
correspond to three clusters in [1]. Bottom: point clouds of numeric number 8 with noise. β1-
barcode indicates two persistent signals. Two possible clusters are detected as two loops, that is,
1-degree topological feature.
To study the connectivity of a space, the space need not be represented as a
point cloud. All we need to know is how close the points are in a space where they
live. Thus point clouds or matrices of (dis-)similarity measurements among other
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data forms are input data for analysis of persistent homology. A good reference for
algebraic topology and persistent homology is [6].
3.1 Vietoris-Rips complex and topological descriptors
We will further explain Figure 1 and then introduce three topological descriptors,
barcode, persistence diagram [7] and persistence landscape [2]. A collection of point
cloud data in a metric space is converted to a combinatorial graph whose edges are
determined by closeness between the points. While a graph captures connectivity
and clustering of data, it ignores higher dimensional features. This idea of graph
can be extended to a simplicial complex, which is a collection of simplices.
Suppose there is a finite set of points {vi}n1 in Rd and (dis-)similarity measure
is denoted as d(vi,v j). A k−simplex is a set of all points x ∈ Rd such that x =
∑ki=1,aivi, where ∑ai = 1,ai ≥ 0. It is easy to picture low dimensional simplices; a
0-simplex a vertex, a 1-simplex an edge joining two vertices, a 2-simplex a triangle,
a 3-simplex a tetrahedron. Vietoris-Rips complex Vε is a set of simplices whose
vertices have pairwise distance within d(vi,v j)≤ ε. Algebraic topology adds group
structure onto the complex, Hk(Vε), called k−th homology group. For coefficients
in a field, Hk(Vε) is a vector space, whose basis consist of linearly independent
k−dimensional cycles that are not boundaries. The k−th Betti number βk, is the rank
of Hk(Vε) and counts the number of k−dimensional holes of a simplcial complex.
At each fixed ε , homology group Hk(Vε) can be calculated, but computational
topologists think of persistence. The simplical complexes grow as ε increases, that
is, Vε ⊆ Vε∗, for ε ≤ ε∗, this inclusion induces a linear map, Hk(Vε)→ Hk(Vε∗).
This allows us to examine the filtration of homology. The evolution of the simplicial
complexes over increasing values of ε can be completely tracked using barcodes or
persistence diagrams. Barcode is the multiset of intervals (ε ′,ε ′′), where ε ′ and ε ′′
indicate birth and death time of a topological feature. Alternatively, the birth and
death times can be represented by a point (ε ′,ε ′′) in R2. The collection of these
points in R2 is a persistence diagram (see Figure 5). Vietoris-Rips complex and its
evolution are demonstrated with random points selected from a double annulus, see
Figure 1 above.
In a simple summary, the point cloud data are transformed to barcodes or persis-
tence diagrams in each dimension. Is it possible to calculate means and variances of
barcodes or persistence diagrams? It is well known that the Fre´chet mean of barcode
(persistence diagram) is not unique. Many researchers have advanced in develop-
ing theories in this research area [8, 24]. Bubenik [2] introduced a third topologi-
cal descriptor, persistence landscape. Given an interval (b,d), with b ≤ d, define a
function leading to an isosceles triangle, f(b,d) : R→ R, f(b,d) = min(t−b,d− t)+,
where u+ = max(u,0). The persistence landscape corresponds to a multiset of in-
tervals {(bi,di) : bi ≤ di} and to a set of functions, {λ (k, t) : N×R→ R} where :
λ (k, t) is the k−th largest value of { f(bi,di)}. See an illustration in Figure 4.
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Fig. 4 (Left) Three intervals in a barcode. (Middle) Isosceles triangles of intervals. (Right) Persis-
tence landscape.
3.2 Statistical Inference with Persistence Landscape
On N×R, the product of the counting measure on N and the Lebesgue measure on
R are used. The persistence landscape, λ (k, t) :N×R→R, is bounded and nonzero
on a bounded domain. Hence persistence landscape belongs to Lp(N×R), with a
metric induced by p-integrable functions and hence is a separable Banach space [2].
Bubenik also showed that when p ≥ 2, with finite first and second moments, per-
sistence landscape satisfies a Strong Law of Large Numbers (SLLN) and a Central
Limit Theorem (CLT). Suppose Λ1, . . . ,Λn are the random variables corresponding
to persistence landscapes. The vector space structure of Lp(N×R) induces the mean
landscape as the pointwise mean, λ¯ (k, t) = 1n ∑
n
i=1λi(k, t).
On p-integrable space, Lp(N×R), where p ≥ 2 and under the assumption of
finite first and second moments, for any continuous linear functional f , the random
variable f (λ (k, t)) also satisfies SLLN and CLT [16]. There are many choices of
f , but the integration of λ might be a natural choice, f (λ (k, t)) = ∑
k
∫
Rλ (k, t)dt.
It has a good interpretation; the values of f are an enclosed total area of all curves
λ (k, t). Choice of f might depend on data, see other choices in [2]. With the inte-
gration as a functional choice, we are ready to set hypotheses. Let Y1 = f (λ1(k, t))
and Y2 = f (λ2(k, t)) be random variables for groups 1 and 2. We let µ1 and µ2 be
corresponding population means. The hypothesis of interest is
H0 : µ1−µ2 = 0 vs. Ha : µ1−µ2 6= 0. (1)
We also consider the similarity measure between persistence landscapes as well
as between persistence diagrams. The measure between persistence landscape is
defined as the p-norm of difference. Suppose there are two samples that have land-
scapes denoted as λ1(k, t) and λ2(k, t). Then the Lp-norm is defined in (2). This
compares pairwise the area under the contours between λ1(k, t) and λ2(k, t)
||λ1−λ2||p =
(
∑
k
∫
R
|λ1(k, t)−λ2(k, t)|p
)1/p
. (2)
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For our data, we will calculate the persistence landscape distance using both L1 and
L2 norm in (2). Wasserstein distance (see ([6], for example) is a popular measure
of dissimilarity between persistence diagrams. All the results based on persistance
landscape (p = 1,2) and Wasserstein distance are similar and so all our statistics and
presentations are based on L2 norm in the following sections.
4 Topological data analysis
The computation of the Vietoris-Rips complex, which is computationally intensive,
is carried out using the phom package in R [34] on the Westgrid computer network.
All 45 samples had intervals in barcode in degrees zero and one. However in de-
gree two, only 12 of the pre-FMT samples and 15 of the post-FMT samples have
intervals in barcode. Persistence diagram makes visual pairwise comparisons eas-
ier than barcode. Figure 5 shows the corresponding persistence diagrams of patient
10 before and after the FMT treatment. At first glance there does not appear to be
(a) Degree 0-patient 10 (b) Degree 1-patient 10
Fig. 5 Persistence diagrams for patient 10 before (in blue) and after (in red) FMT in (a) degrees
zero and (b) one. Note that the triangles in (a) have birth at time zero but are moved slightly for
visual purposes.
anything interesting but there are some general trends. We observe that the degree 0
persistence diagram for the pre-FMT samples have components that die a lot sooner
than those in the post-FMT samples. Similarly, the birth and death times of these
loops are shorter for the pre-FMT samples than for the post-FMT samples. These
observations may indicate that there could be a true difference in the topological
structure in degrees zero and one between the two groups. On the other hand, many
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of the intervals in degree one are very short, thus what we observe may be noise
rather than signal.
Unlike barcode or persistence diagrams, we can calculate means and variances of
persistence landscapes. Figure 6 below, shows the average persistence landscapes of
pre-FMT and post-FMT samples in degree 0 and 1. The trend in average persistence
landscapes is the same as in persistence diagrams or barcodes, that is, the post-FMT
samples have slightly longer intervals than the pre-FMT in degree 0 and 1.
(a) pre-FMT-degree 0 (b) post-FMT-degree 0 (c) pre-FMT-degree 1 (d) post-FMT-degree 1
Fig. 6 Average persistence landscapes for pre-FMT and post-FMT patients in degrees zero and
one. In degree zero, the post-FMT group has a denser grouping of contours, which means that
there are more clusters than in the post-FMT samples. In degree one, the pre-FMT group has three
persistent loops on average and the post-FMT sample has two. However, the post-FMT sample
loops are more persistent than the pre-FMT samples. We note that the vertical scales in the plots in
degree 0 and 1 are different.
Quadratic discriminant analysis (QDA) was performed on the β0- and β1-Isomap
embedded coordinates. Three groups are well separated on the plane of both degree
0 and 1. It is interesting to see that the donors are grouped on one side and pre-
FMT patients on the other side, and post-FMT patients between the two. This is in
complete agreement with what clinicians believe is happening and it is frequently
reported that patients gut microbiome take on the characteristics of the donor mi-
crobiome following an FMT, see [32, 37, 14].
It would have been very interesting to compare the matched donor and the pa-
tient after FMT, but this information was not recorded during this study, [17]. The
classification in R2 space in degree 0 in Figure 7 shows the patients 7, 16 and 19
post-FMT, become much like donors, particularly donors 2 and 3. Patients 9 and 15
post-FMT did not seem improved as they are similar to the cases pre-FMT. The clas-
sification in R2 space in degree 1 in 7 show a few post-FMT patients (7, 10, 15) are
close to the donors after FMT while most post-FMT patients remain similar to pre-
FMT. Following [17], a clinical trial comparing the efficacy of frozen versus fresh
FMT has been completed, see [18]. Here stool samples were collected at pre-FMT,
followed by day-10, week-5, week-13 following a patients last FMT along with the
exact donor stool sample pairing. Sequencing of this data is currently underway.
We recall that our ‘raw’ data was the dissimilarity matrix between 147 uniques
DNA sequences per subject, so a total of forty five 147× 147 matrices. For each
matrix, we construct a Vietoris-Rips complex, then calculate persistence landscapes
which enables us to perform statistical inference. Hypothesis test (1) were carried
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(a) Degree 0 (b) Degree 1
Fig. 7 Classification in two-dimensional space. Three groups are well separated on the R2 for
both degree 0 and 1. The canonical functions for both β0- and β1- Isomap discriminate pre-FMT
patients and donors on each quadrant while post-FMT patients located between the two. (Left) The
patients 7, 16 and 19 after FMT treatment classified as donors, possibly indicating their donors
might be 2 and 3. Patients 9 and 15 do not appear ‘improved’ after FMT as they are classified as
the group of patients before the treatment. The patients 7, 16 and 19 are not only similar to donors
but also further away their pre-FMT position. This may indicate they have improved the most after
the treatment. (Right) In terms of loops in DNA sequences, a cluster of post-FMT patients are
similar to the group of post-FMT treated patients. Donor 7 could be the donor for patient 10.
out to comparing pre-FMT and post-FMT samples. The p−values of the paired
t−tests are 0.0064, 0.0083 and 0.2591 in degree 0, 1, and 2, respectively. Since all
the analysis above is based on 147 sequences randomly chosen from those patients
whose number of of DNA sequences are bigger than 147, we repeated analysis 10
times with independent 147 DNA samples. The test statistics and p−values for 10
runs are similar showing consistency of result regardless of which 147 DNA se-
quences were applied.
Hypothesis tests show significant difference of topological features in degree 0
and 1 between patients before and after FMT treatment. For degree 0, this implies
that the number of clusters and their persistence on DNA sequences in pre-FMT
samples are different from those in post-FMT samples. For degree 1, this implies
that the number of loops (cycles) and their persistence in DNA sequences in pre-
FMT samples are different from those post-FMT samples. We present DNA se-
quences as points cloud in R3 and observe patterns of clustering and loops in DNA
sequences in the following section.
4.1 Clusters and loops in DNA sequences
Applying dimensional reduction methods; Isomap and multidimensional scaling
(MDS), to dissimilarity measure between DNA sequences, we project the DNA
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sequences to R3 and obtain embedded coordinates. Scree plots appear to indicate
embedding dimension of the DNA sequences is 3. The residual variance in MDS
was much higher than for Isomap, hence figures based on Isomap are presented
below.
(a) Donor 3 (b) Post 7
(c) Pre 19 (d) Post 19
Fig. 8 Plots (a) and (b): 147 DNA sequences donor 3 and post-FMT patient 7 on Isomap embed-
ded coordinates. Both samples have roughly the same number of clusters. In general, donors and
patients that were close on the classification in R2 in Figure 7 had similar number of clusters. Plots
(c) and (d) 147 DNA sequences of pre-FMT and and post-FMT patient 19 on Isomap embedded
coordinates. There are several clusters in both pre-FMT/post-FMT patient 19. The number of clus-
ters in DNA sequences of post-FMT patient 19 is higher, but there are many clusters formed by a
single DNA.
Figure 8 shows the Isomap embedded coordinates for donor 3, post-FMT patient
7 and pre-FMT/post-FMT patient 19. From the Figure 8, it can be seen that donor 3
and post-FMT patient 7 have a similar spread among the sequences and there are 2-
3 distinct clusters. We have also noticed that donor 2 and post-FMT patient 18 also
have similar structures. The donors generally have a wider spread, which would
indicate more diverse DNA sequences and hence a healthier gut microbiome. For
the number of of clusters, there are higher number of clusters in post-FMT samples,
however some clusters contain only one DNA sequence and are more spread out.
For example, there are about 5 groups in pre-FMT patient 19; many clusters with
fewer DNA sequences in each cluster in post-FMT patient 19. Ignoring the singleton
clusters, we observe two large clusters in post-FMT patient 19. This information was
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shown in Figure 8 as well as on barcode and persistence diagram. The two clusters in
post-FMT patient 19 can be seen in the barcode diagram as the two points that have
the highest ‘death’ time. The spread out clusters in pre-FMT 19 are shown as the
bars that have the earlier birth and earlier death times (figures are not shown here).
This trend is visible in other samples and this might explain the small p−value for
testing the difference in area under the persistence landscapes which was calculated
in Section 4.
5 Conclusions
We illustrated how topological data analysis can be applied to similarity measures
data of DNA sequences. DNA sequence data was analyzed using three summary
statistics of persistent homology; namely, barcodes, persistence diagrams and per-
sistence landscapes. The main objective was to see if there are any differences in the
topological feature of DNA sequences in the gut microbiome of CDI patients before
and after FMT treatment.
From visual inspection of barcodes and persistence diagrams it was seen that the
components in dimensions zero and one died sooner in the pre-FMT samples than
in the post-FMT samples. Persistence landscapes were able to present this differ-
ence more formally, showing that there is a difference in the average area under the
persistence landscapes for pre-FMT and post samples. Alternative interpretation of
this was that there was a difference in the number and size of clusters in dimension
zero, and the number and size of loops in dimension one. The post-FMT samples
had more clusters than the post samples, whereas there was no visually obvious
difference in the size of the loops, but the loops were bigger for the post samples.
We performed discriminant analysis on β0,β1 -Isomap embedded coordinates.
The classification on two dimensional space for both degree 0 and 1 show good
separation among three groups. For degree 0, the first two discriminant function
separates pre-FMT patients and donors, and post-FMT patients sit between the two.
For degree 1, the first two discriminant function separates pre-FMT and post-FMT
patients and donors are between the two.
The major drawbacks of this analysis is that information about individual se-
quences is lost. This project looked at the topological structure created by the se-
quences but no details were provided about the individual sequences. As the micro-
biological technology and methods improve it may be interesting to incorporate this
information. Also of interest would be meaningful identification of bacterial species.
Studies of the 16S rRNA gene only measure presence of the species, but do not say
anything about their functionality. For the latter one has to turn to the metabolome
which is currently under investigation with the patients in [18].
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